Companies / LifeStance Health Group, Inc.

LifeStance Health Group, Inc.

Nasdaq: LFSTCIK 1845257SCOTTSDALE, AZ

Financials · FY2025

Revenue$1.42B
Net income$9.66M
Total debt$275.50M
Cash$225.94M
Diluted EPS
Shares outstanding382.1M

Ownership

382.1M shares outstanding · as of Jul 29, 2026
9.5%Insiders
Ownership
Insiders9.51%36,330,352
10%+ / strategic41.47%158,451,398
Institutions50.44%192,707,275
Public float0.00%0

Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 12

View all →
Insider% of sharesShares
Tpg Gp a, LLC10% owner
29.25%111,744,614
7.65%29,209,776
0.90%3,425,315
Bourdon DavidCEOChief Executive Officer · Director
0.37%1,398,247
Pardo RyanSee Remarks · Director
0.29%1,102,742
McGroarty RyanSee Remarks
0.20%772,235
Varanakis AnnChief People Officer
0.11%422,037
Miller Lisa KFormerChief Operating Officer
0.09%329,201
Paunovich VukasinFormerChief Technology Officer
0.08%309,296
Eken Stephanie CarinFormerChief Medical Officer
0.03%115,107

Institutional holders 220

View all →

Activity

Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ΔPosition afterImpact
Q2 2026
as of
BlackRock, Inc.
13F manager
AddCommon Stock$184.84M+17.3M
+90.41%
36,348,507
9.51% of shares
high
Q2 2026
as of
State Street Corporation
13F manager
AddCommon Stock$48.89M+4.6M
+124.62%
8,228,351
2.15% of shares
medium
Q3 2024
as of
Barclays PLC
13F manager
AddCommon Stock$8.33M+1.2M
+1499.93%
1,268,904
0.33% of shares
medium
Q3 2025
as of
Barclays PLC
13F manager
AddCommon Stock$8.25M+1.5M
+74.65%
3,508,552
0.92% of shares
medium
Q1 2026
as of
First Trust Advisors LP
13F manager
AddCommon Stock$3.80M+597K
+127.00%
1,066,191
0.28% of shares
low
Q1 2026
as of
D. E. Shaw & Co., Inc.
13F manager
AddCommon Stock$3.22M+505K
+363.58%
644,152
0.17% of shares
low
Q1 2026
as of
Orbimed Advisors LLC
13F manager
NewCommon Stock$3.19M+500K
500,000
0.13% of shares
low
Q2 2025
as of
Barclays PLC
13F manager
AddCommon Stock$3.01M+582K
+40.76%
2,008,865
0.53% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Fmr LLCPassive13G/A46,706,784

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
LFSTCommon StockEquity53228F101BBG01138DGZ7